Abstract
Metastasis is a multistep process involving detachment of tumour cells from the primary site, dissemination through the blood stream, arrest in capillary beds, adherence to the vascular wall, dissolution of the basal lamina, migration and growth in extravascular spaces (see Poste and Fidler 1980, Terranova et al 1986, for reviews). The involvement of platelets in the metastatic process has been suggested on the basis of clinical and experimental data (see Gasic 1984, Mehta 1984, Jamieson et al 1987, Weiss et al 1989 for reviews). In the present paper, we will discuss the possible in vitro and in vivo interactions between platelets, tumour cells, endothelial cells and sub-endothelial matrix, the relevance of these multiple interactions for the pathogenesis of metastases and their possible pharmacological modulation for a selective anti-metastatic therapy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abecassis J, Millon-Collard R, Klein-Soyer C, Nicora F, Fricker J-P, Beretz A, Eber M, Muller D, Cazenave J-P (1987) Adhesion of human breast cancer cell line MCF-7 to human vascular endothelial cells in culture. Enhancement by activated platelets. Int J Cancer 40: 525–531.
Akiyama SK, Nagata K, Yamada KM (1990) Cell surface receptors for extracellular matrix components. Biochim Biophys Acta 1031: 91–110
Bastida E, Ordinas A, Giardina SL, Jamieson GA (1982)
Differentiation of platelet-aggregating effects of human tumor cell lines based on inhibition studies with apyrase, hirudin, and phospholipase. Cancer Res 42:4348–4352
Bastida E, Almirall L, Buchanan MR, Haas TA, Lauri D, Orr WB (1987) Effects of 13-HODE and HETE’s in tumour cell/endothelial cell interactions. Thromb Haemost 58: 315
Bastida E, Ordinas A (1988) Platelet contribution to the formation of metastatic foci: the role of cancer cell-induced platelet activation. Haemostasis 18: 29–36
Bastida E, Almirall L, Bertomeu MC, Ordinas A (1989) Influence of shear stress on tumor-cell adhesion to endothelial-cell extracellular matrix and its modulation by fibronectin. Int J Cancer 43: 1174–1178
Boukerche H, Berthier-Vergnes 0, Tabone E, Doré J-F, Leung LLK, McGregor JL (1989a) Platelet-melanoma cell interaction is mediated by the glycoprotein IIb-IIIa complex. Blood 74: 658–663
Boukerche H, Berthier-Vergnes O, Bailly M, Doré J-F, Leung LLK, McGregor JL (1989b) A monoclonal antibody (LYP18) directed against the blood platelet glycoprotein IIb/IIIa complex inhibits human melanoma growth in vivo. Blood 74: 909–912
Bretti S, Neri P, Lozzi L, Rustici M, Comoglio P, Giancotti F, Tarone G (1989) Inhibition of experimental metastasis of murine fibrosarcoma cells by oligopeptide analogues to the fibronectin cell-binding site. Int J Cancer 43: 102–106
Buchanan MR, Bastida E (1987) The role of 13-HODE and HETEs in vessel wall/circulating blood cell interaction. Agents and Actions 22: 337–339
Charon MH, Poggi A, Donati MB, Marguerie G (1990) Synthetic peptide with antithrombotic activity. In: Rivier JE and Marshall GR (eds) Peptides. Chemistry, structure and biology. ESCOM, Leiden pp 82–83
Chmielewska J, Poggi A, Mussoni L, Donati MB, Garattini S (1980) Blood coagulation changes in JW Sarcoma, a new metastasizing tumour in mice. Europ J Cancer 16: 1399–1407
Chopra H, Hatfield JS, Chang YS, Grossi I, Fitgerald LA, O’Gara CY, Marnett LJ, Diglio CA, Taylor JD, Honn KV (1988) Role of tumor cell cytoskeleton and membrane glycoprotein IRGpIIb/IIIa in platelet adhesion to tumor cell membrane and tumor cell-induced platelet aggregation. Cancer Res 48: 3787–3800
Costantini V, Fuschiotti P, Allegrucci M, Agnelli G, Nenci GC, Fioretti MC (1988) Platelet-tumor cell interaction: effect of prostacyclin and a synthetic analog on metastasis formation. Cancer Chemother Pharmacol 22: 289–293
Crissman JD, Hatfield JS, Menter DG, Sloane B, Honn KV (1988) Morphological study of the interaction of intravascular tumor cells with endothelial cell and subendothelial matrix. Cancer Res 48: 4065–4072
Delaini F, Giavazzi R, De Bellis Vitti G, Alessandri G, Mantovani A, Donati MB (1981) Tumor sublines with different metastatic capacity induce similar blood coagulation changes in the host. Br J Cancer 43: 100–104
Deuel TF, Senior RM, Huang JS, Griffin GL (1982) Chemotaxis of monocytes and neutrofils to platelet derived growth factor. J Clin Invest 69: 1046–1049
Donati MB, Poggi A (1980) Malignancy and haemostasis. Br J Heamatol 44: 173–182
Donati MB, Rotilio D, Delaini F, Giavazzi R, Mantovani A, Poggi A (1982) Animal models for the study of platelet-tumor cell interactions. In: Interaction of platelets and tumor cells. Jamieson GA (ed) A.R.Liss Publisher, New York, NY, pp 159–174
Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. New Engl J Med 315: 1650–1659
Estrada J, Nicolson G (1984) Tumor-cell-platelet aggregation does not correlate with metastatic potential of rat 13762NF mammary adenocarcinoma tumor cell clones. Int J Cancer 34: 101–105
Frazier WA (1987) Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells. J Cell Biol 105: 625–632
Gasic G, Gasic T (1962) Removal of sialic acid from the cell coat in tumor cells and vascular endothelium and its effects on metastasis. Proc Natl Acad Sci USA 48: 1172–1177
Gasic GJ, Gasic TB, Stewart CC (1968) Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 61:45–52 Gasic GJ, Gasic TB, Murphy S (1972) Anti-metastatic effect of aspirin. Lancet 2: 713
Gasic GJ, Gasic TB, Galanti N, Johnson T, Murphy S (1973) Platelettumor-cell interactions in mice: the role of platelets in spread of malignant disease. Int J Cancer 11: 704–718
Gasic GJ (1984) Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metastasis Rev 3: 99–116
Gastpar H (1972) The inhibition of the cancer cell stickiness by pyrimido-pyrimidine derivatives induced by inhibition of platelet aggregation. Acta Med Scand Suppl 525: 269–271
Giavazzi R, Alessandri G, Spreafico F, Garattini S, Mantovani A (1980) Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours. Br J Cancer 42:462–472 Goustin AS, Leof EB, Shipley GD, Moses HL (1986) Growth factors and cancer. Cancer Res 46: 1015–1029
Grignani G, Pacchiarini L, Almasio P, Pagliarino M, Gamba G, Rizzo SC, Ascari E (1983) Characterization of the platelet-aggregating activity of cancer cells with different metastatic potential. Int J Cancer 38: 237–244
Grossi IM, Fitzgerald LA, Umbarger LA, Nelson KK, Diglio CA, Taylor D, Honn KV (1989) Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid. Cancer Res 49: 1029–1037
Heino J, Massagué J (1989) Transforming growth factor-beta switches the pattern of intergrins expressed in MG-63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin. J Biol Chem 264: 21806–21811
Heldin C-H and Westermark B (1984) Growth factors: mechanism of action and relation to oncogenes. Cell 37: 9–20
Heldin C-H and Westermark B (1989) Growth factors as transforming proteins. Eur J Biochem 184: 487–496
Hilgard P, Heller H, Schmidt CG (1976) The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL). Z Krebsforsch Klin Onkol 86: 243–250
Honn KV, Cicone B, Skoff A (1981) Prostacyclin: a potent antimetastatic agent. Science 212: 1270–1272
Honn KV (1983) Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin thromboxane A2 system. Clin Expl Metastasis 1: 103–114
Honn KV, Onoda JM, Diglio CA, Sloane BF (1983) Calcium channel blockers:potential antimetastatic agents. Proc Soc Exp Biol Med 174: 16–19
Honn KV, Onoda JM, Diglio CA, Carufel MM, Taylor JD, Sloane BF (1984) Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker nimodipine. Clin Expl Metastasis 2: 61–72
Honn KV, Onoda JM, Pamapalona K, Battaglia M, Neagos G, Taylor JD, Diglio CA, Sloane BF (1985) Inhibition by dihydropyridine class calcium channel blockers of tumor cell-platelet-endothelial cell interactions in vitro and metastasis in vivo. Biochem Pharmacol 34: 235–241
Huang TF, Holt JC, Lukasiewicz, Niewiarowski S (1987) Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. J Biol Chem 262: 16157–16163
Humphries MJ, Olden K, Yamada KM (1986) A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 233: 467–470
Humphries MJ, Yamada KM, Olden K (1988) Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16–F10 murine melanoma cells. J Clin Invest 81: 782–790
Hynes RO (1987) Integrins: a family of cell surface receptors. Cell 48: 549–554
Jamieson GA, Bastida E, Ordinas A (1987) Interaction of platelets and tumour cells. In: Maclntyre and Gordon J (eds) Platelets in Biology and Pathology III. Elsevier Science Publisher, Amsterdam, pp 161–189
Karpatkin S, Ambrogio C, Pearlstein E (1984) Lack of effect of in vivo prostacyclin on the development of pulmonary metastases in mice following intravenous injection of CT26 colon carcinoma, Lewis lung carcinoma, or B16 amelanotic melanoma cells. Cancer Res 44: 3880–3883
Karpatkin S, Pearlstein E, Ambrogio C, Coller BS (1988) Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest 81: 1012–1019
Katz IR, Thorbecke GJ, Bell MK, Yin J-Z, Clarke D, Zucker MB (1986) Protease-induced immunoregulatory activity of platelet factor 4. Proc Natl Acad Sci USA 83: 3941–3945
Kimura AK, Mehta P, Xiang J, Lawson D, Dugger D, Kao K-J, Ambrose LL (1987) The lack of correlation between experimental metastatic potential and platelet aggregating activity of B16 melanoma clones viewed in relation to tumor cell heterogeneity. Clin Expl Metastasis 5: 125–133
Knudsen KA, Smith L, Smith S, Karczewski J, Tuszynski GP (1988a) Role of IIb-IIIa-like glycoproteins in cell-substratum adhesion of human melanoma cells. J Cell Physiol 136: 471–478
Knudsen KA, Tuszynski GP, Huang T-F, Niewiarowski S (1988b) Trigramin, an RGD-containing peptide from snake venom, inhibits cell-substratum adhesion of human melanoma cells. Exp Cell Res 179: 42–49
Lampugnani MG, Crawford N (1987) Tumor cell induced platelet aggregation: studies with cloned metastatic and non metastatic variants. Invasion Metastasis 7: 311–324
Lauri D, Bertomeu MC, Orr FW, Bastida E, Sander D, Buchanan MR (1990) Interleukin-1 increases tumor cell adhesion to endothelial cells through an RGD dependent mechanism: in vitro and in vivo studies. Clin Exp Metastasis 8: 27–32
Lerner WA, Pearlstein E, Ambrogio C, Karpatkin S (1983) A new mechanism for tumor-induced platelet aggregation. Comparison with mechanisms shared by other tumors with possible pharmacologic strategy toward prevention of metastases. Int J Cancer 31: 463–469
Lichtner RB, Hutchinson G, Wedderbrun N, Hellmann K (1985) Antiplatelet pyrimido-pyrimidines and metastasis. Cancer Treat Rev 12: 221–234
Lyons RM, Moses HL (1990) Transforming growth factors and the regulation of cell proliferation. Eur J Biochem 187: 467–473
Marguerie GA, Edgington TS, Plow EF (1980) Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem 255: 154–161
Mehta P (1984) Potential role of platelets in the pathogenesis of tumor metastasis. Blood 63: 55–63
Menter DG, Steinert BW, Sloane B, Gundlach N, O’Gara CY, Marnett LJ, Diglio C, Walz D, Taylor JD, Honn KV (1987) Role of platelet membrane in enhancement of tumor cell adhesion to endothelial cell extracellular matrix. Cancer Res 47: 6751–6762
Mussoni L, Poggi A, de Gaetano G, Donati MB (1978) Effect of ditazole, an inhibitor of platelet aggregation, on a metastasizing tumour in mice. Br J Cancer 37: 126–129
Nicolson GL (1988) Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev. 7, 143–188.
Nistér M, Heldin C-H, Westermark B (1986) Clonal varation in the production of a platelet-derived growth factor-like protein and expression of corresponding receptors in a human malignant glioma. Cancer Res 46: 332–340
Pearlstein E, Cooper LB, Karpatkin S (1979) Extraction and characterization of a platelet-aggregating material from SV40transformed mouse 3T3 fibroblasts. J Lab Clin Med 93: 332–344
Pearlstein E, Salk PL, Yogeeswaran G, Karpatkin S (1980) Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line. Proc Natl Acad Sci USA 77: 4336–4339
Pearlstein E, Ambrogio C, Gasic G, Karpatkin S (1981) Inhibition of the platelet aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor: Dansylarginine N-(3-ethyl-1,5-pentanediyl) amide. Cancer Res 41: 4535–4539
Phillips DR, Charo IF, Parise LV, Fitzgerald LA (1988) The platelet membrane glycoprotein IIb-IIIa complex. Blood 71: 831–843
Pierschbacher MD and Ruoslahti E (1984) Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309: 30–33
Poggi A, Polentarutti N, Donati MB, de Gaetano G, Garattini S (1977) Blood coagulation changes in mice bearing Lewis lung carcinoma,a metastasizing tumor. Cancer Res 37: 272–277
Poggi A, Donati MB, Garattini S (1981) Fibrin and cancer cell growth: Problems in the evaluation of experimental models. In: Donati MB, Davidson JF, Garattini S (eds) Malignancy and the Hemostatic System, Raven Press, New York, N.Y., pp 89–101
Poggi A, Vicenzi E, Cioce V, Wasteson A (1988) Platelet contribution to cancer cell growth and migration: the role of platelet growth factors. Haemostasis 18: 18–28
Poste G, Fidler I (1980) The pathogenis of cancer metastasis. Nature 283: 139–146
Rickles FR, Hancock WW (1988) Antimetastatic Agents. II. Summary of the interactions of tumor cells with blood coagulation factors, platelets, fibrinolytic factors, and inflammatory cells and their soluble mediators: potential for therapeutic interventions. Seminars in Thrombosis and Hemostasis 14: 126–132
Roberts DD, Sherwood JA, Ginsburg V (1987) Platelet thrombospondin mediates attachment and spreading of human melanoma cells. J Cell Biol 104: 131–139
Ross R, Raines EW, Bowen-Pope DF (1986) The biology of platelet-derived growth factor. Cell 46: 155–169
Ruoslahti E and Pierscbacher MD (1987) New perspectives in cell adhesion: RGD and integrins. Science 238: 491–497
Saiki I, Murata J, Iida J, Sakurai T, Nishi N, Matsuno K, Azuma I (1989) Antimetastatic effect of synthetic polypeptides containing repeated structures of the cell adhesive arg-gly-asp (RGD) and tyrile-gly-ser-arg ( YIGSR) sequences. Br J Cancer 60: 722–728
Sporn MB, Roberts AB (1986) Peptide growth factors and inflammation, tissue repair, and cancer. J Clin Invest 78: 329–332
Sporn MB, Roberts AB, Wakefield LM, Assoian RK (1986) Transforming growth factor-beta: biological function and chemical structure. Science 233: 532–534
Terranova VP, Hujanen ES, Martin GR (1986) Basement membrane and the invasive activity of metastatic tumor cells. J Natl Cancer Inst 77: 311–316
Tanaka NG, Tohgo A, Ogawa H (1986) Platelet-aggregating activities of metastasizing tumor cells. V. In situ role of platelets in hematogenous metastases. Invasion Metastasis 6: 58–68
Tuszynski GP, Rothman VL, Murphy A, Seigler K, Smith L, Smith S, Karczeweski J, Knudesn K (1987a) Thrombospondin promotes cell-substratum adhesion. Science 236: 1570–1573
Tuszynski GP, Gasic TB, Rothman VL, Knudsen K, Gasis GJ (1987b) Thrombospondin, a potentiator of tumor cell metastasis. Cancer Res 47: 4130–4133
Ugen KE, Mahalingam M, Klein PA, Kao K-J (1988) Inhibition of tumor cell-induced platelet aggregation and experimental tumor metastasis by the synthetic gly-arg-gly-asp-ser peptide. J Natl Cancer Inst 80: 1461–1466
Vicenzi E, Lampugnani MG, Bolognese Dalessandro AP, Niewiarowska A, de Gaetano G, Donati MB (1987) Dissociation between thromboxane generation and metastatic potential in cells from a murine fibrosarcoma. Studies with a selective thromboxane synthase inhibitor. Int J Cancer 39: 488–491
Warren BA (1981) Cancer cell-endothelial reactions: the microinjury hypothesis and localized thrombosis in the formation of micrometastases. In: Donati MB, Davidson JE, Garattini S (eds) Malignancy and the hemostasic system. Raven Press, New York 5–26
Waterfield MD, Scrace GT, Whittle N, Stroobant P, Johnsson A, Wasteson A, Westermark B, Heldin C-H, Huang JS, Deuel TT (1983) Platelet-derived growth factor is structurally related to the putative transforming protein p28 sis of simian sarcoma virus. Nature 304: 35–39
Weiss L, Orr WF, Honn KV (1989) Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis. Clin Expl Metastasis 7: 127–167
Westermark B, Johnsson A, Paulsson Y, Betsholtz C, Heldin C-H, Helyn M, Rodeck U, Koprowski H (1986) Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor ( PDGF) and produce a PDGF-like growth factor. Proc Natl Acad Sci USA 83: 7197–7200
Wood S (1958) Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber. AMA Archives of Pathology 66: 550–568
Wood S, Hilgard P (1972) Aspirin and tumour metastasis. Lancet 2: 713.
Zacharski LR, Henderson WG et al (1981) Effect of warfarin on survival in small cell carcinoma of the lung.Veterans Administration Study n.75. JAMA 245: 831–835.
Zacharski LR, Moritz TE et al (1988) Effect of mopidamol on survival in carcinoma of the lung and colon:final report of Veterans Administration cooperative study No.188. J Natl Cancer Inst 80: 9097
Zacharski LR, Donati MB (1989) Registry of clinical trials of antithrombotic drugs in cancer. Thromb Haemost 61: 526–528
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Poggi, A., Beviglia, L., Charon, M.H., Rossi, C., Marguerie, G., Donati, M.B. (1990). Anti-Platelet Treatment of Metastasis. In: Harenberg, J., Heene, D.L., Stehle, G., Schettler, G. (eds) New Trends in Haemostasis. Veröffentlichungen aus der Geomedizinischen Forschungsstelle der Heidelberger Akademie der Wissenschaften, vol 1990 / 1990/3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84318-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-84318-1_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53275-0
Online ISBN: 978-3-642-84318-1
eBook Packages: Springer Book Archive